文献速递哮喘

年龄对哮喘儿童临床特征、药物管理与急性发作的影响

Influence of age on clinical characteristics, pharmacological management and exacerbations in children with asthma.
PubMed 文献 · Thorax · 2024-01-18

结果显示不同年龄组临床特征、发作率和危险因素不同,5-8岁发作率最高(13.7/100人年),延迟诊断与各年龄段发作增加相关,提示指南应细化年龄分层。

要点

  • 5-8岁哮喘儿童急性发作率最高(13.7/100人年),高于9-11岁(10.0)和青少年(6.7)。
  • 5-8岁组湿疹、食物/药物过敏和咳嗽比例最高,青少年组超重/肥胖、气传过敏原致敏和呼吸困难比例最高。
  • 延迟诊断在5-8岁组最常见,且与所有年龄段发作增加相关。

核心结论

  • 儿童哮喘的基线特征和急性发作率因诊断年龄组而异,临床指南应比5-16岁宽泛范围更细致地考虑诊断时年龄。

研究设计与样本

  • 采用多变量Cox比例风险模型分析急性发作相关因素。

主要发现

  • 5-8岁组湿疹、食物/药物过敏和咳嗽比例最高,青少年组超重/肥胖、气传过敏原致敏、呼吸困难和仅使用短效β2受体激动剂比例最高。
  • 急性发作率(每100人年,95%CI):5-8岁=13.7(13.4-13.9),9-11岁=10.0(9.8-10.4),青少年=6.7(6.5-7.0)。
  • 5-8岁组发作危险因素中男性、湿疹和食物/药物过敏关联强;≥9岁组肥胖和气传过敏原致敏关联强。
  • 所有儿童中,更高的社会经济剥夺与急性发作显著相关。
  • 延迟诊断在5-8岁组最常见,且与所有年龄段发作增加相关。

临床怎么用

  • 对5-8岁哮喘儿童应关注湿疹、食物/药物过敏等共病,并警惕延迟诊断带来的发作风险。
  • 对9岁及以上儿童应重视肥胖和气传过敏原致敏的评估与管理。
  • 临床管理应考虑诊断时年龄分层,而非统一按5-16岁宽泛范围处理。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Asthma trials and guidelines often do not distinguish between adolescents and younger children. Using a large English data set, we evaluated the impact of age on asthma characteristics, management and exacerbations. METHODS: Primary care medical records, 2004-2021, were linked to hospital records. Children were categorised by age at diagnosis and followed until the next age bracket. Ages (based on management guidelines) were 5-8 years, 9-11 years and adolescents (12-16 years). Characteristics evaluated included body mass index, allergies and events before and after diagnosis (symptoms, medication). Exacerbation incidence was calculated. Multivariable Cox proportional hazards determined associations with exacerbations. RESULTS: 119 611 children were eligible: 61 940 (51.8%) 5-8 years, 32 316 (27.7%) 9-11 years and 25 355 (21.2%) adolescents. Several characteristics differed by age; children aged 5-8 years had the highest proportion with eczema, food/drug allergy and cough, but adolescents had the highest proportion with overweight/obesity, aeroallergen sensitisation, dyspnoea and short-acting-beta-agonist only use. Exacerbation rates were highest in the youngest children (per 100 person-years (95% CI): 5-8 years =13.7 (13.4-13.9), 9-11 years =10.0 (9.8-10.4), adolescents =6.7 (6.5-7.0)). Exacerbation risk factors also differed by age; 5-8 years: male, eczema and food/drug allergy were strongly associated, but for children ≥9 years old, obesity and aeroallergen sensitisation were strongly associated. For all children, higher socioeconomic deprivation was significantly associated with having an exacerbation. Delayed diagnosis was most common in children aged 5-8 years and was associated with increased exacerbations across all ages. CONCLUSION: Children's baseline characteristics and exacerbation rates varied according to their age group. Clinical guidelines should consider age at time of diagnosis more discretely than the broad range, 5-16 years, as this appears to impact on asthma severity and management.

来源:Thorax,查看原文。版权归原作者所有。

引用

  1. Khalaf, Bush, Saglani, et al. Influence of age on clinical characteristics, pharmacological management and exacerbations in children with asthma. Thorax. 2024. PMID: 38071524. doi:10.1136/thorax-2023-220603

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。